Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Liabilities and Shareholders Equity (2021 - 2025)

Roivant Sciences (ROIV) has disclosed Liabilities and Shareholders Equity for 5 consecutive years, with $5.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 9.79% year-over-year to $5.2 billion, compared with a TTM value of $20.8 billion through Dec 2025, down 19.29%, and an annual FY2025 reading of $5.4 billion, down 24.72% over the prior year.
  • Liabilities and Shareholders Equity was $5.2 billion for Q4 2025 at Roivant Sciences, up from $5.1 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $7.3 billion in Q4 2023 and bottomed at $2.1 billion in Q3 2023.
  • Average Liabilities and Shareholders Equity over 5 years is $4.1 billion, with a median of $2.8 billion recorded in 2021.
  • The sharpest move saw Liabilities and Shareholders Equity skyrocketed 231.95% in 2023, then decreased 24.72% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $2.8 billion in 2021, then decreased by 21.31% to $2.2 billion in 2022, then surged by 231.95% to $7.3 billion in 2023, then decreased by 20.79% to $5.8 billion in 2024, then decreased by 9.79% to $5.2 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for ROIV at $5.2 billion in Q4 2025, $5.1 billion in Q3 2025, and $5.0 billion in Q2 2025.